Update in hematology and oncology

Annals of Internal Medicine

Volumn 152, Issue 10, 2010, Pages 655-662

  Drews, Reed E ^a   Shulman, Lawrence N ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; BICALUTAMIDE; CARBOPLATIN; CETUXIMAB; CYTOCHROME P450 2C9; DABIGATRAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLUTAMIDE; GEFITINIB; GOSERELIN; HEMOGLOBIN; K RAS PROTEIN; LETROZOLE; LEUPRORELIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PACLITAXEL; PLACEBO; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TAMOXIFEN; UNCLASSIFIED DRUG; VITAMIN K GROUP; VKORC1 PROTEIN; WARFARIN; HEMATOLOGIC AGENT;

ACUTE HEART INFARCTION; ADJUVANT THERAPY; ADVANCED CANCER; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COLORECTAL CANCER; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIABETIC PATIENT; DIGESTIVE SYSTEM CANCER; DIGITAL RECTAL EXAMINATION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; ECHOGRAPHY; EMBOLISM PREVENTION; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; GRAFT RECIPIENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOGENETICS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT DURATION; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM; FEMALE; HEMATOLOGIC DISEASE; MALE; MASS SCREENING; NEOPLASM; REVIEW; RISK FACTOR;

FEMALE; HEMATOLOGIC AGENTS; HEMATOLOGIC DISEASES; HUMANS; MALE; MASS SCREENING; NEOPLASMS; RISK FACTORS;

EID: 77952982731     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-10-201005180-00244     Document Type: Article

References (5)

1. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al; CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355:2085-98. [PMID: 17108343]
2. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al; CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071-84. [PMID: 17108342]
3. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-8. [PMID: 19297566]
4. Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al; Spanish Lung Cancer Group. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361:958-67. [PMID: 19692684]
5. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102:14-25. [PMID: 20007921]